News Daily News Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019 Yael L. Maxwell December 20, 2019
News Daily News FDA Approves Icosapent Ethyl for Reducing CVD Events Michael O'Riordan December 13, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Daily News Many ASCVD Patients Skimp on CV Meds Due to Costs: US Survey Caitlin E. Cox November 25, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Conference News ESC 2019 Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories Yael L. Maxwell September 06, 2019
News Daily News New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides Michael O'Riordan August 21, 2019
News Daily News A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November Yael L. Maxwell August 14, 2019
News Daily News No Need for Niacin? Meta-analysis Argues the End Is Nigh Yael L. Maxwell April 22, 2019
News Conference News ACC 2019 REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events Yael L. Maxwell March 22, 2019
News Conference News AHA 2018 REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides Todd Neale November 10, 2018
News Daily News Prescription Omega-3 Fatty Acids Cut Cardiovascular Events: REDUCE-IT Shelley Wood September 24, 2018
News Daily News Un Nuevo Análisis del COGENT Avala el Uso de PPI en Pacientes con Dosis Bajas de Aspirina Caitlin E. Cox March 23, 2016
News Daily News ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy April 29, 2015
News Daily News ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple April 29, 2015
News Daily News Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA Caitlin E. Cox April 19, 2013